Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00180375
Status:
COMPLETED
Last Update Posted:
2017-02-23
First Post:
2005-09-12
Brief Title:
OPERA French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator
Sponsor:
Boston Scientific Corporation
Organization:
Boston Scientific Corporation
Study Overview
Official Title:
OPERA French Observational Study on Patients Implanted With a Guidant PRIZM or Vitality Defibrillator
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates the date of the first appropriate andor inappropriate therapy in patients implanted with a Guidant PRIZM or VITALITY defibrillator and is evaluating eventual predictive risk factors for appropriateinappropriate therapies as well as the influence of the programmed parameters on these therapies
Detailed Description:
The registry measured the times to and studied the determinants of first appropriate FAT and inappropriate FIT therapy delivered by single dual and triple chamber CRT-D ICD implanted for primary and secondary prevention indications
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 902194 | None | None | None |